Glioma Stem Cells: Novel Data Obtained by Single-Cell Sequencing.

Area of Science:

• Neuro-oncology
• Cancer genomics
• Immunotherapy

Background:

• Gliomas are primary central nervous system (CNS) tumors with significant inter-tumoral heterogeneity.
• The 2021 WHO classification reflects genetic insights, improving prognosis for some glioma subtypes.
• Intratumoral heterogeneity, particularly cancer stem cells (CSCs), remains a key research challenge.

Purpose of the Study:

• To review the concept of glioma stem cells (GSCs).
• To discuss single-cell sequencing advancements in studying glioma intratumoral heterogeneity.
• To highlight recent findings on cell composition variations in adult-type diffuse gliomas.

Main Methods:

• Review of current literature on glioma stem cells.
• Analysis of single-cell sequencing data for glioma research.
• Focus on adult-type diffuse gliomas (astrocytoma, oligodendroglioma, glioblastoma).

Main Results:

• Single-cell sequencing reveals significant intratumoral heterogeneity in gliomas.
• Novel data clarify inconsistencies in previous GSC research.
• Variations in cell composition identified across glioma subtypes.

Conclusions:

• Understanding intratumoral heterogeneity is crucial for advancing glioma treatment.
• New insights support the development of targeted therapies and cell-based immunotherapies.
• Single-cell sequencing is pivotal for future glioma research and treatment strategies.